Temozolomide in the era of precision medicine

A Thomas, M Tanaka, J Trepel, WC Reinhold… - Cancer research, 2017 - AACR
Abstract In the January 1, 2017, issue of Cancer Research, Nagel and colleagues
demonstrate the value of assays that determine the DNA repair capacity of cancers in …

[HTML][HTML] Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases

H Soliman, S Das, DA Larson, A Sahgal - Oncotarget, 2016 - ncbi.nlm.nih.gov
Stereotactic radiosurgery (SRS) is an established non-invasive ablative therapy for brain
metastases. Early clinical trials with SRS proved that tumor control rates are superior to …

Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases

S Kabraji, J Ni, S Sammons, T Li… - Clinical Cancer …, 2023 - AACR
Purpose: Brain metastases can occur in up to 50% of patients with metastatic HER2-positive
breast cancer. Because patients with active brain metastases were excluded from previous …

Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter …

R Ruggieri, S Naccarato, R Mazzola, F Ricchetti… - Radiation …, 2018 - Springer
Background Linac-based stereotactic radiosurgery or fractionated stereotactic radiotherapy
(SRS/FSRT) of multiple brain lesions using volumetric modulated arc therapy (VMAT) is …

Treatment strategies for low-grade glioma in adults

NA Oberheim Bush, S Chang - Journal of oncology practice, 2016 - ascopubs.org
Diffuse low-grade gliomas include oligodendrogliomas and astrocytomas. The recent 2016
WHO classification has now updated the definition of these tumors to include molecular …

Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues

A Sahgal, M Ruschin, L Ma, W Verbakel… - Neuro …, 2017 - academic.oup.com
Over the past three decades several randomized trials have enabled evidence-based
practice for patients presenting with limited brain metastases. These trials have focused on …

Neurosurgical management of patients with brain metastasis

MA Hatiboglu, K Akdur, R Sawaya - Neurosurgical review, 2020 - Springer
Brain metastasis is a serious complication in patients with systemic cancer. The main goal of
the treatment in patients with brain metastasis is to control the disease in the brain, to …

Diagnostic accuracy of PET for differentiating true glioma progression from post treatment-related changes: a systematic review and meta-analysis

M Cui, RI Zorrilla-Veloz, J Hu, B Guan, X Ma - Frontiers in Neurology, 2021 - frontiersin.org
Purpose: To evaluate the diagnostic accuracy of PET with different radiotracers and
parameters in differentiating between true glioma progression (TPR) and post treatment …

Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain?

S Kabraji, J Ni, NU Lin, S Xie, EP Winer, JJ Zhao - Clinical Cancer Research, 2018 - AACR
The brain is the most common site of first metastasis for patients with HER2-positive breast
cancer treated with HER2-targeting drugs. However, the development of effective therapies …

Tumor‐targeted nanotherapeutics: overcoming treatment barriers for glioblastoma

AS Wadajkar, JG Dancy, DS Hersh… - Wiley …, 2017 - Wiley Online Library
Glioblastoma (GBM) is a highly aggressive and lethal form of primary brain cancer.
Numerous barriers exist to the effective treatment of GBM including the tightly controlled …